Código QR (código de barras bidimensional)

Efficacy and safety of mogamulizumab in Sézary syndrome with concomitant Crohn’s disease

Dear Editor, Mogamulizumab is a humanized, defucosylated monoclonal antibody targeting CC chemokine receptor 4 (CCR4), expressed on malignant T cells in cutaneous T-cell lymphomas (CTCL), particularly mycosis fungoides and Sézary syndrome. By enhancing antibody-dependent cellular cytotoxicity, mo...

תיאור מלא

שמור ב:
Principais autores: Cosimo Di Raimondo, Edoardo Mortato, Pier Paolo Di Domenico, Luca Bianchi, Marco Galluzzo
פורמט: Artigo
שפה:Inglês
יצא לאור: PAGEPress Publications 2026-05-01
סדרה:Dermatology Reports
נושאים:
Mogamulizumab
Sézary syndrome
Crohn’s disease
גישה מקוונת:https://journals.pagepress.net/dr/article/view/10823
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים